Key result
A case of stent thrombosis occurred within a sirolimus-eluting stent two years after implantation despite chronic aspirin therapy, presenting as acute ST-elevation myocardial infarction.
Case Report (n=1)
This case highlights the risk of very late stent thrombosis with drug-eluting stents and suggests the need for long-term follow-up.
Single case of very late DES thrombosis leaves open optimal antiplatelet duration; should not change practice.
Drug-eluting stents are widely used to prevent restenosis after coronary angioplasty. We here report a case of stent thrombosis within a sirolimus-eluting stent occurring two years after stent implantation, while the patient was on chronic aspirin therapy. The patient presented with acute ST-elevation myocardial infarction and pulmonary oedema; stent thrombosis was successfully treated with coronary angioplasty and deployment of a new coronary stent. This case suggests that long-term follow-up is needed in clinical studies on drug-eluting stents.
No takes yet. Share an insight, caveat, or question.
Pasceri et al. (2006) conducted a case report in Stent thrombosis (n=1). Sirolimus-eluting stent was evaluated on Stent thrombosis. A case of stent thrombosis occurred within a sirolimus-eluting stent two years after implantation despite chronic aspirin therapy, presenting as acute ST-elevation myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: